COMMUNIQUÉS West-GlobeNewswire

Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - Belén Garijo nommée administratrice et Directrice générale de Sanofi
29/04/2026
Assemblée Générale Annuelle du 29 avril 2026 Belén Garijo nommée administratrice et Directrice générale de Sanofi Paris, le 29 avril 2026 . L’Assemblée Générale Mixte des actionnaires de Sanofi s’est réunie le 29 avril [...]
NADP advocates greater access to care through dental coverage
29/04/2026
Association represents dental benefits industry at Advocacy in Action DALLAS, April 29, 2026 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) underscored its commitment to expanding access to dental [...]
Carbios files its 2025 Universal Registration Document
29/04/2026
Clermont-Ferrand (France), 29 April 2026 (6:00 pm CEST). Carbios (Euronext Growth Paris: ALCRB) announces to its shareholders and the financial community that its 2025 Universal Registration Document, including: the [...]
Availabilty of 2026 AGM preparatory documents
29/04/2026
Press Release Paris, 29 April, 2026 Combined General Meeting of May 27, 2026 Availability of preparatory documents EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 27 [...]
EUROBIO SCIENTIFIC : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
29/04/2026
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Paris, le 29 avril 2026 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro pour la transplantation [...]
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025
29/04/2026
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025 Pièce jointe EBS - RFA 2025
U.S. News & World Report Announces "Best of" 2026 Ratings for Legend Senior Living® Residences
29/04/2026
WICHITA, Kan., April 29, 2026 (GLOBE NEWSWIRE) -- U.S. News & World Report has named 27 residences of Legend Senior Living among its "Best of" for 2026 in their respective categories and 11 additional Legend [...]
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
29/04/2026
Novel procedure combines image-guided tumor cryolysis with intratumoral immunotherapy infusion, with early clinical findings in metastatic prostate cancer FORT LAUDERDALE, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- [...]
Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW)
29/04/2026
Oral presentation on the impact of concomitant steroid use in ulcerative colitis (UC) scheduled for May 5, 2026, at 9:30am CDT AUSTIN, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Cristcot, a clinical-stage pharmaceutical [...]
Beacon Therapeutics Announces Presentations at the ARVO 2026 Annual Meeting
29/04/2026
LONDON and CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company with a mission to save and [...]
Modalité de mise à disposition des documents préparatoires à l'AG 2026
29/04/2026
Communiqué de presse Paris, le 29 avril 2026 Assemblée Générale du 27 mai 2026 Modalités de mise à disposition des documents préparatoires Les actionnaires d’EUROAPI sont invités à participer à l’Assemblée générale [...]
Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias
29/04/2026
SAN FRANCISCO, April 29, 2026 (GLOBE NEWSWIRE) -- Laguna Biotherapeutics, Inc. (Laguna), a clinical-stage biotechnology company focused on novel live bacterial therapeutics, today announced that the U.S. Food and Drug [...]
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
29/04/2026
ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the first [...]
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
29/04/2026
Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference, May 2–5, 2026, in Chicago IRVINE, Calif., April 29, 2026 (GLOBE NEWSWIRE [...]
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
29/04/2026
Sangamo’s common stock to transition trading from The Nasdaq Capital Market to OTCQB Venture Market beginning May 5, 2026 RICHMOND, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a [...]
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
29/04/2026
EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA submission in Q4 2026 NEEDHAM, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Candel [...]
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
29/04/2026
Presentation will showcase recent data from multiple clinical studies evaluating dual-targeting CD19/BCMA CAR-T therapy candidate TPST-2003 Results support clinical benefit of parallel-structure dual-targeting CAR [...]
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6
29/04/2026
DALLAS, April 29, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene [...]
BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026
29/04/2026
BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today [...]

Pages